Books |
|
|
The Morality of Embryo Use, Cambridge University Press, 2008. |
|
Papers |
|
|
‘The Nonindividuation Argument Against Zygotic Personhood,’ |
|
|
Philosophy 81: 463–503 (2006). |
|
‘Intellectual Honesty,’ |
|
|
Synthese 145: 177–232 (2005). |
|
‘A Proposed Stem Cell Research Policy,’ |
|
|
Stem Cells 23: 1023–1027(2005). |
|
‘Wishful Thinking Will Not Obviate Embryo Use,’ |
|
|
Stem Cell Reviews 1: 309–315 (2005). |
|
‘Dialogue Concerning Natural Appropriation,’ |
|
|
Synthese 136: 321–336 (2003). |
|
‘The Set of Embryo Subjects,’ |
|
|
Nature Biotechnology 21: 482–483 (2003). |
|
‘The Set Theoretic Ambit of Arrow’s Theorem,’ |
|
|
Synthese 126:443–472 (2001). |
|
‘Morals and Primordials,’ |
|
|
Science 292: 1659–1660 (2001). |
|
‘Expressing a Consensus on Candour,’ |
|
|
Nature 402: 577–578 (1999). Online Supplementary Material |
|
‘The Intromissibility of a Paretian Athletic Director,’ |
|
|
Brookings Review 16 (no. 4): 44–48 (1998). |
|
‘Affirmative Action in Higher Education as Redistribution,’ |
|
|
Public Affairs Quarterly 11: 117–140 (1997). |
|
‘Distributive Justice in Competitive Access to Intercollegiate |
|
|
Athletic Teams Segregated by Sex,’ |
|
|
Studies in Philosophy and Education 16: 347–372 (1997). |
|
‘The Logical Geography of Concepts and Shared |
|
|
Responsibilities Concerning Research Misconduct,’ |
|
|
Academic Medicine 71: 595–603 (1996). |
|
‘Norms for Patents Concerning Human and Other Life Forms,’ |
|
|
Theoretical Medicine 17: 279–314 (1996). |
|
Collections |
|
|
‘Developmental Potential,’ in Tuomas Tahko, ed., |
|
|
Contemporary Aristotelian Metaphysics. |
|
|
Cambridge University Press, 2012. |
|
‘Ethical Considerations,’ in Anthony Atala, Robert Lanza, |
|
|
James A. Thomson, and Robert M. Nerem, eds., |
|
|
Principles of Regenerative Medicine. Elsevier, 2007. |
|
Special issue, ‘Candor in Science,’ ed. |
|
|
Synthese 145, no. 2 (2005). |
|
‘Ethics of Patents on Human Life Forms,’ in Thomas H. |
|
|
Murray and Maxwell J. Mehlman, eds., Encyclopedia of |
|
|
Ethical, Legal, and Policy Issues in Biotechnology. |
|
|
Wiley, 2000. |
|
|
|